One shot for two viruses: new combo vaccine trial shows promise
NCT ID NCT06864143
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new combination vaccine called mRNA-1083 that aims to protect against both flu and COVID-19 in a single shot. About 1,320 adults aged 18 to 64 took part. Researchers measured the immune response and checked for side effects to see if the combo vaccine works as well as separate vaccines.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Artemis Research (Headlands)
San Diego, California, 92103, United States
-
Clinical Research Atlanta (Headlands)
Stockbridge, Georgia, 30281, United States
-
DM Clinical Research - Bellaire
Houston, Texas, 77081, United States
-
DM Clinical Research - Boston
Brookline, Massachusetts, 02446, United States
-
DM Clinical Research - Chicago
Melrose Park, Illinois, 60160, United States
-
DM Clinical Research - Detroit
Southfield, Michigan, 48076, United States
-
DM Clinical Research - Philadelphia
Philadelphia, Pennsylvania, 19107, United States
-
DM Clinical Research - Tomball
Tomball, Texas, 77375, United States
-
Headlands Research Scottsdale
Scottsdale, Arizona, 85260, United States
-
Trial Management Associates, LLC
Wilmington, North Carolina, 28403, United States
-
Trial Management Associates, LLC
Myrtle Beach, South Carolina, 29572, United States
-
Velocity Clinical Research, Boise
Meridian, Idaho, 83642, United States
-
Velocity Clinical Research, Cincinnati, Mt. Auburn
Cincinnati, Ohio, 45219, United States
-
Velocity Clinical Research, Cincinnati, Springdale
Cincinnati, Ohio, 45246, United States
-
Velocity Clinical Research, Lafayette
Lafayette, Louisiana, 70809, United States
-
Velocity Clinical Research, Norfolk
Norfolk, Nebraska, 68701, United States
-
Velocity Clinical Research, Rockville
Rockville, Maryland, 20854, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Flu vaccine showdown: which shot protects seniors best?
- Can a simple breath test catch flu in High-HIV regions?
- Can a new pill keep High-Risk COVID-19 patients out of the hospital?
- Can a simple mask stop the flu? 2,000 volunteers put it to the test
- Can a stronger flu shot better protect seniors?
- Flu shot showdown: Cell-Grown vs recombinant vaccine put to the test